Jason Douglas Wilson, Chief Financial Officer at REATA PHARMACEUTICALS INC (RETA), sold 5,604 shares at $93.62 ($527K) on 2019-03-15, disclosed to the SEC on 2019-03-19.
Open-market sale of $527k RETA by Chief Financial Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $93.62 | 4,000 | $374K | 71.1% |
| 2 | $95.11 | 1,604 | $153K | 28.9% |
| Total | $94.04 avg | 5,604 | $527K | 100% |
| Filing → |
| RETA | SELL | 2019-10-15 | $5.5M | — | Filing → |
| RETA | SELL | 2019-08-16 | $420K | — | Filing → |
| RETA | SELL | 2019-07-17 | $574K | — | Filing → |